Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study

Addiction (Abingdon, England)

Volumn 111, Issue 8, 2016, Pages 1416-1427

  Ling, Walter ^a   Hillhouse, Maureen P ^a   Saxon, Andrew J ^b   Mooney, Larissa J ^a   Thomas, Christie M ^a   Ang, Alfonso ^a   Matthews, Abigail G ^c   Hasson, Albert ^a   Annon, Jeffrey ^a   Sparenborg, Steve ^d   Liu, David S ^d   McCormack, Jennifer ^c   Church, Sarah ^e   Swafford, William ^f   Drexler, Karen ^g   Schuman, Carolyn ^h   Ross, Stephen ⁱ   Wiest, Katharina ^j   Korthuis, P Todd ^k   Lawson, William ^l   Brigham, Gregory S ^m   Knox, Patricia C ⁿ   Dawes, Michael ^o   Rotrosen, John ^p   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c EMMES CORPORATION   (United States)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f Addict Res and Treatment Services   (United States)

^g ATLANTA VA MEDICAL CENTER   (United States)

^h Bay Area Addiction Research and Treatment   (United States)

ⁱ BELLEVUE HOSPITAL CENTER   (United States)

^j CODA Portlad OR USA ^*

^k OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^l HOWARD UNIVERSITY   (United States)

^m Maryhaven   (United States)

ⁿ Recovery Centers of King County (RCKC)   (United States)

^o SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^p NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Buprenorphine + naloxone; cocaine use disorder; double blind; multi site trial; naltrexone; pharmacotherapy; placebo controlled; treatment

Indexed keywords

BUPRENORPHINE PLUS NALOXONE; NALTREXONE; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST;

ADULT; COCAINE DEPENDENCE; COGNITIVE THERAPY; CONTROLLED STUDY; DELAYED RELEASE FORMULATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; ANALGESICS, OPIOID; BUPRENORPHINE, NALOXONE DRUG COMBINATION; COCAINE-RELATED DISORDERS; COGNITIVE THERAPY; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; TREATMENT OUTCOME;

EID: 84978152293     PISSN: None     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.13375     Document Type: Article

References (27)